Christophe Pierre Weber

Chief Executive Officer, Takeda Pharmaceutical Company.

Companies

Takeda Pharmaceutical CompanyBoard member Mar 18, 2026 to now¹
Takeda Pharmaceutical CompanyChief executive officer Mar 18, 2026 to now¹
Boston ScientificBoard member Feb 24, 2026 to now²
Takeda Pharmaceutical CompanyPresident Mar 18, 2026 to Jul 6, 2026¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Takeda Pharmaceutical Company TAK418,803 shares³$8.2M at $19.64Apr 27, 2026
Boston Scientific BSX3,786 shares⁴$167.6K at $44.26May 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 7, 2026Granted 1,140 shares of Boston Scientific⁴
May 7, 2026Granted 1,767 shares of Boston Scientific⁴
Apr 27, 2026Granted 165,370 shares of Takeda Pharmaceutical Company³
Apr 27, 2026Granted 78,900 shares of Takeda Pharmaceutical Company³
Mar 2, 2026Granted 323 shares of Boston Scientific⁵
Mar 2, 2026Granted 556 shares of Boston Scientific⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTakeda Pharmaceutical Company, Board member
2
SEC EDGARBoston Scientific, Board member
3
SEC EDGARTakeda Pharmaceutical Company shares after the filing of Apr 27, 2026
4
SEC EDGARBoston Scientific shares after the filing of May 7, 2026
5
SEC EDGARForm 4 filed Mar 4, 2026